Tatsuaki Morokata

942 total citations
45 papers, 763 citations indexed

About

Tatsuaki Morokata is a scholar working on Immunology, Transplantation and Physiology. According to data from OpenAlex, Tatsuaki Morokata has authored 45 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 13 papers in Transplantation and 13 papers in Physiology. Recurrent topics in Tatsuaki Morokata's work include Renal Transplantation Outcomes and Treatments (13 papers), Asthma and respiratory diseases (13 papers) and T-cell and B-cell Immunology (9 papers). Tatsuaki Morokata is often cited by papers focused on Renal Transplantation Outcomes and Treatments (13 papers), Asthma and respiratory diseases (13 papers) and T-cell and B-cell Immunology (9 papers). Tatsuaki Morokata collaborates with scholars based in Japan, United States and Norway. Tatsuaki Morokata's co-authors include Jun Ishikawa, Toshimitsu Yamada, Keiko Suzuki, Takatoshi Yamada, Koichiro Takahashi, Koichiro Morihira, Tatsuo Kawai, Megan Sykes, Meredith Chittenden and Giovanna Andreola and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Tatsuaki Morokata

44 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tatsuaki Morokata Japan 16 303 206 177 113 105 45 763
Bret Verhoven United States 10 416 1.4× 472 2.3× 173 1.0× 39 0.3× 65 0.6× 20 896
K H Stenzel United States 18 311 1.0× 336 1.6× 71 0.4× 90 0.8× 101 1.0× 39 943
Julia K. Archbold Australia 15 616 2.0× 324 1.6× 47 0.3× 41 0.4× 135 1.3× 21 1.1k
Victor Tkachev United States 13 405 1.3× 338 1.6× 56 0.3× 25 0.2× 169 1.6× 36 905
Pamella J. Ford United States 11 221 0.7× 557 2.7× 36 0.2× 29 0.3× 164 1.6× 19 892
B M McManus United States 11 162 0.5× 272 1.3× 32 0.2× 74 0.7× 60 0.6× 16 744
Maylene E. Wagener United States 20 736 2.4× 228 1.1× 28 0.2× 181 1.6× 279 2.7× 38 1.2k
Zhenyu Xiao China 24 339 1.1× 778 3.8× 70 0.4× 12 0.1× 188 1.8× 52 1.4k
Lynne P. Rutzky United States 12 91 0.3× 261 1.3× 27 0.2× 286 2.5× 212 2.0× 18 893
John M. Fidler United States 21 555 1.8× 349 1.7× 24 0.1× 22 0.2× 130 1.2× 60 1.2k

Countries citing papers authored by Tatsuaki Morokata

Since Specialization
Citations

This map shows the geographic impact of Tatsuaki Morokata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuaki Morokata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuaki Morokata more than expected).

Fields of papers citing papers by Tatsuaki Morokata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatsuaki Morokata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuaki Morokata. The network helps show where Tatsuaki Morokata may publish in the future.

Co-authorship network of co-authors of Tatsuaki Morokata

This figure shows the co-authorship network connecting the top 25 collaborators of Tatsuaki Morokata. A scholar is included among the top collaborators of Tatsuaki Morokata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatsuaki Morokata. Tatsuaki Morokata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakamura, Koji, et al.. (2022). Potential benefit of the cathepsin S inhibitor, ASP1617, as a treatment for systemic lupus erythematosus. European Journal of Pharmacology. 919. 174826–174826. 7 indexed citations
2.
Maeda, Masashi, Koji Nakamura, Hiroyuki Satake, et al.. (2022). Impacts of dosing and drug withdrawal period on tacrolimus-based triple therapy in a non-human primate renal transplantation model. Transplant Immunology. 75. 101704–101704.
3.
Yamajuku, Daisuke, Satoshi Kubo, Koji Nakamura, et al.. (2021). Discovery of a novel Igβ and FcγRIIB cross-linking antibody, ASP2713, and its potential application in the treatment of systemic lupus erythematosus. International Immunopharmacology. 101(Pt B). 108343–108343. 2 indexed citations
4.
Ito, Misato, et al.. (2019). The PI3Kδ selective inhibitor AS2541019 suppresses donor-specific antibody production in rat cardiac and non-human primate renal allotransplant models. International Immunopharmacology. 75. 105756–105756. 5 indexed citations
5.
Nakamura, Koji, Yutaka Nakajima, T Nakagawa, et al.. (2018). Effective suppression of donor specific antibody production by Cathepsin S inhibitors in a mouse transplantation model. European Journal of Pharmacology. 838. 145–152. 6 indexed citations
6.
Taguchi, Katsunari, et al.. (2018). Anti-IL-23 receptor monoclonal antibody prevents CD4+ T cell-mediated colitis in association with decreased systemic Th1 and Th17 responses. European Journal of Pharmacology. 824. 163–169. 16 indexed citations
7.
Nakamura, Koji, Yoko Kaneko, T. Nakanishi, et al.. (2017). Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation model. Transplant Immunology. 46. 14–20. 4 indexed citations
8.
Dun, Hao, Lijun Song, Anlun Ma, et al.. (2017). ASP0028 in combination with suboptimal-dose of tacrolimus in Cynomolgus monkey renal transplantation model. Transplant Immunology. 40. 57–65. 7 indexed citations
9.
Nakamura, Koji, Masamichi Inami, Misato Ito, et al.. (2016). AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts. European Journal of Pharmacology. 796. 69–75. 11 indexed citations
10.
Yamamoto, Rie, Jun Hirose, Masashi Maeda, et al.. (2014). ASP4058, a Novel Agonist for Sphingosine 1-Phosphate Receptors 1 and 5, Ameliorates Rodent Experimental Autoimmune Encephalomyelitis with a Favorable Safety Profile. PLoS ONE. 9(10). e110819–e110819. 22 indexed citations
11.
Nakanishi, T., et al.. (2010). Effect of the inosine 5′-monophosphate dehydrogenase inhibitor BMS-566419 on renal fibrosis in unilateral ureteral obstruction in rats. International Immunopharmacology. 10(11). 1434–1439. 5 indexed citations
12.
Yoshino, Taiji, Jun Ishikawa, Keiko Ohga, et al.. (2007). YM-58483, a selective CRAC channel inhibitor, prevents antigen-induced airway eosinophilia and late phase asthmatic responses via Th2 cytokine inhibition in animal models. European Journal of Pharmacology. 560(2-3). 225–233. 68 indexed citations
13.
Suzuki, Keiko, Tatsuaki Morokata, Koichiro Morihira, et al.. (2005). In vitro and in vivo characterization of a novel CCR3 antagonist, YM-344031. Biochemical and Biophysical Research Communications. 339(4). 1217–1223. 27 indexed citations
14.
15.
Morokata, Tatsuaki, et al.. (2004). Effect of a novel interleukin-5 receptor antagonist, YM-90709, on antigen-induced eosinophil infiltration into the airway of BDF1 mice. Immunology Letters. 98(1). 161–165. 8 indexed citations
16.
Morokata, Tatsuaki, et al.. (2002). Characterization of YM-90709 as a novel antagonist which inhibits the binding of interleukin-5 to interleukin-5 receptor. International Immunopharmacology. 2(12). 1693–1702. 17 indexed citations
17.
Aoki, Motonori, et al.. (2000). Effect of a Novel Anti-Inflammatory Compound, YM976, on Antigen-Induced Eosinophil Infiltration into the Lungs in Rats, Mice, and Ferrets. Journal of Pharmacology and Experimental Therapeutics. 295(3). 1149–1155. 29 indexed citations
18.
Morokata, Tatsuaki. (1999). Differential susceptibility of C57BL/6 and DBA/2 mice to ovalbumin-induced pulmonary eosinophilia regulated by Th1/Th2-type cytokines. Immunology Letters. 70(2). 127–134. 15 indexed citations
19.
Kato, Takuma, Tatsuaki Morokata, Osamu Igarashi, et al.. (1997). Costimulatory Effect of IL-12 on the Activation of Naive, Memory CD4+T Cells, and Th1 Clone. Cellular Immunology. 176(1). 50–58. 19 indexed citations
20.
Morokata, Tatsuaki, Takuma Kato, Osamu Igarashi, & Hideo Nariuchi. (1995). Mechanism of enhanced antigen presentation by B cells activated with anti‐μ plus interferon‐γ: Role of B7‐2 in the activation of naive and memory CD4+ T cells. European Journal of Immunology. 25(7). 1992–1998. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bret Verhoven Breakdown of academic impact, for papers by K H Stenzel Breakdown of academic impact, for papers by Julia K. Archbold Breakdown of academic impact, for papers by Victor Tkachev Breakdown of academic impact, for papers by Pamella J. Ford Breakdown of academic impact, for papers by B M McManus Breakdown of academic impact, for papers by Maylene E. Wagener Breakdown of academic impact, for papers by Zhenyu Xiao Breakdown of academic impact, for papers by Lynne P. Rutzky Breakdown of academic impact, for papers by John M. Fidler
Rankless by CCL
2026